Possible Scenarios of Testosterone and Anabolic Androgenic Steroids Use in and Outside Medicine

Abstract

Anabolic hormones, particularly testosterone and anabolic androgenic steroids (AAS), serve a range of applications with distinct goals, benefits, and risks. This article aims to clarify four primary scenarios in which these hormones are used, to aid in reducing misunderstandings and promoting more evidence-based discussions. The first scenario, testosterone replacement therapy (TRT), is well-documented as a treatment for hypogonadism, offering improvements in body composition, metabolic health, and cardiovascular outcomes with proper supervision. The second scenario involves therapeutic use of AAS in cases of significant catabolism, muscle loss, or other clinical conditions requiring anabolic support. Here, controlled studies underscore the potential of AAS to improve muscle mass, bone density, and physical function, though clinical practice underutilizes these therapies. A third, more debated scenario covers the controlled use of supraphysiological doses of testosterone and AAS for performance and aesthetics. Research, including randomized controlled trials (RCTs), has shown measurable benefits in body composition and physical strength with minimal adverse effects when appropriately monitored. However, such uses remain controversial and are not widely endorsed by medical organizations due to ethical and safety concerns. The final scenario contrasts sharply with the others, detailing the risks associated with unregulated AAS abuse. This includes prolonged use, high dosages, poor-quality products from the underground market, and polypharmacy, which collectively heighten the risk of severe health consequences. This chaotic pattern of abuse complicates the assessment of AAS’s specific impact on health due to numerous confounding factors. A clearer distinction between these scenarios could enhance academic and clinical discourse, leading to more precise recommendations. By acknowledging the varied contexts in which AAS and testosterone are used, healthcare providers and researchers may make better-informed decisions, advancing safer practices and more effective guidelines.